Acta Neuropharmacologica››2013,Vol. 3››Issue (5): 13-26.
Previous ArticlesNext Articles
ZHANDSUN Dong-ting, LUO Su-lan
Online:2013-10-26Published:2014-06-27Contact:罗素兰，Tel: +86-0898-66289538，E-mail: luosulan2003@163.comAbout author:长孙东亭，男，副研究员；研究方向：海洋药物研究Supported by:
国家自然科学基金项目(No.41366002)，长江学者和创新团队发展计划项目（No.IRT1123）， 海南省社会发展科技专项项目（No.SF201328），海口市重点科技计划项目（No.2013-16）
ZHANDSUN Dong-ting, LUO Su-lan.Development of Human Experimental Pain Models[J]. Acta Neuropharmacologica, 2013, 3(5): 13-26.
| [1] Drewes A M, Gregersen H, Arendt-Nielsen L. Experimental pain in gastroenterology: A reappraisal of human studies[J]. Scand J Gastroenterol, 2003, 38(11):1115–1130. [2] Arendt-Nielsen L, Curatolo M, Drewes A. Human experimental pain models in drug development: Translational pain research[J]. Curr Opin InvestigDrugs, 2007, 8:41–45. [3] K Sunil kumar Reddy, M U R Naidu, P Usha Rani, et al. Human experimental pain models: A review of standardized methods in drug development[J]. J Res Med Sci, 2012, 17(6): 587–595. [4] Claude Chassaing, Jeannot Schmidt, Alain Eschalier, et al. Hyperalgesia induced by cutaneous freeze injury for testing analgesics in healthy volunteers[J]. Br J Clin Pharmacol, 2006, 61(4):389–397. [5] Wallace M S, Barger D, Schulteis G. The effect of chronic oral desipramine on capsaicin-induced allodynia and hyperalgesia: A double-blinden, placebo-controlled, crossover study[J]. Anaesth Analg, 2002, 95(4):973–978. [6] Michele Curatolo, Steen Petersen-Felix, Lars Arendt-Nielsen. Sensory assessment of regional anaesthesia in humans.A review of methods and applications[J]. Anesthesiology, 2000, 93(6):1517–1530. [7] Brian E Cairns, Peter Svensson, Kelun Wang, et al. Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males[J]. Exp Brain Res, 2006, 169(4):467–472. [8] Alexander Korotkov, Milos Ljubisavljevic, Johan Thunberg, et al. Changes in human regional cerebral blood flow following hypertonic saline induced experimental muscle pain: A positron emission tomography study[J]. Neurosci Lett, 2002, 335(2):119–123. [9] Victor Babenko, Thomas Graven-Nielsen, Peter Svensson, et al. Experimental human muscle pain induced by intramuscular injections of bradykinin, serotonin and substance P[J]. Eur J Pain, 1999, 3(2):93–102. [10] Laura A Frey Law, Kathleen A Sluka, Tara McMullen, et al. Acidic buffer induced muscle pain evokes referred pain and mechanical hyperalgesia in humans[J]. Pain, 2008, 140(2):254–264. [11] Helle Andersen, Lars Arendt-Nielsen, Peter Svensson, et al. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans[J]. Exp Brain Res, 2008, 191(3):371–382. [12] Trine Andresen, Camilla Staahl, Alexander Oksche, et al. Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain[J]. Br J Pharmacol, 2010, 164(3):934–945. [13] Asbjorn M Drewes, Klaus-Peter Schipper, Georg Dimcevski, et al. Multi-model induction and assessment of allodynia and hyperalgesia in the human oesophagus[J]. Eur J Pain, 2003, 7(6):539–549. [14] Louvel D, Delvaux M, Staumont G, et al. Intracolonic injection of glycerol: A model for abdominal pain in irritable bowel syndrome? [J]. Gastroenterology, 1996, 110(2):351–361. [15] Longhurst J C. Chemosensitive abdominal visceral afferent[M]. In: Gebhart GF, editor. Visceral pain. Seattle WA: IASP Press, 1995: 99–132. [16] Curatolo M, Petersen-Felix S, Arendt-Nielsen L, et al. Adding sodium bicarbonate to lidocaine enhances the depth of epidural blockade[J]. Anesth Analg, 1998, 86(2):341–347. [17] Clifford J Woolf, Max M B. Mechanism-based pain diagnosis: issues for analgesic drug development[J]. Anesthesiology, 2001, 95(1):241–249. [18] Handwerker H O, Kobal G. Psychophysiology of experimentally induced pain[J]. Physiol Rev, 1993, 73(3):639–671. [19] Laursen R J, Graven-Nielsen T, Jensen T S, et al. Referred pain is dependent on sensory input from the periphery: A psychophysical study[J]. Eur J Pain, 1997, 1(4):261–269. [20] Frobert O, Arendt-Nielsen L, Bak P, et al. Electric stimulation of the esophageal mucosa.Perception and brain-evoked potentials[J]. Scand J Gastroenterol, 1994, 29(9):776–781. [21] Liu S S, Ware P D. Differential sensory block after spinal bupivacaine in volunteers[J]. Anesth Analg, 1997, 84(1):115–119. [22] Camilla Staahl, Lona Louring Christrup, Soren Due Andersen, et al. A comparative study of oxycodone and morphine in a multi-model, tissue-differentiated experimental pain model[J]. Pain, 2006, 123(1-2):28–36. [23] Michele Curatolo, Steen Petersen-Felix, Lars Arendt-Nielsen, et al. Epidural epinephrine and clonidine: Segmental analgesia and effects on different pain modalities[J]. Anesthesiology, 1997, 87(4):785–794. [24] Delvaux M, Louvel D, Lagier E, et al. The kappa agonist fedotozine relieves hypersensitivity to colonic distension in patients with irritable bowel syndrome[J]. Gastroenterology, 1999, 116(1):38–45. [25] Asbjorn Mohr Drewes, Klaus-Peter Schipper, Georg Dimcevski, et al. Multimodal assessment of pain in the esophagus: A new experimental model[J]. Am J Physiol Gastrointest Liver Physiol, 2002, 283(1):G95–103. [26] Andrea M Peier, Aziz Moqrich, Anne C Hergarden, et al. A TRP channel that senses cold stimuli and menthol[J]. Cell, 2002, 108(5):705–715. [27] Karen D Davis. Cold-induced pain and prickle in the glabrous and hairy skin[J]. Pain, 1998, 75(1):47–57. [28] Laura A Mitchell, Raymond A R MacDonald, Eric E Brodie. Temperature and the Cold Pressor Test[J]. J Pain, 2004, 5(4):233–237. [29] David Yarnitsky, Jose L Ochoa. Warm and cold specific somatosensory systems.Psychophysical thresholds, reaction times and peripheral conduction velocities[J]. Brain, 1991, 114(Pt 4):1819–1826. [30] Hughes A M, Rhodes J, Fisher G, et al. Assessment of the effect of dextromorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers[J]. Br J Clin Pharmacol, 2002, 53(6):604–612. [31] Arendt-Nielsen L, Chen A C N. Lasers and other thermal stimulators for activation of skin nociceptors in humans[J]. Neurophysiol Clin, 2003, 33(6):259–268. [32] Arendt-Nielsen L. First pain event related potentials to argon laser stimuli: Recording and quantification[J]. J Neurol Neurosurg Psychiatry, 1990, 53(5):398–404. [33] Arendt-Nielsen L. Second pain event related potentials to argon laser stimuli: Recording and quantification[J]. J Neurol Neurosurg Psychiatry, 1990, 53(5):405–410. [34] Svensson P, Bjerring P, Arendt-Nielsen L, et al. Comparison of four laser types for experimental pain stimulation on oral mucosa and hairy skin[J]. Lasers Surg Med, 1991, 11(4):313–324. [35] Wolfgang Koppert, Valeska Brueckl, Christian Weidner, et al. Mechanically induced axon reflex and hyperalgesia in human UV-B burn are reduced by systemic lidocaine[J]. Eur J Pain, 2004, 8(3):237–244. [36] Graven-Nielsen T, Arendt-Nielsen L, Mense S. Thremosensitivity of muscle: High-intensity thermal stimulation of muscle tissue induces muscle pain in humans[J]. J Physiol, 2002, 540(Pt 2):647–656. [37] Sengupta JN, Gebhart GF. Physiology of the gastrointestinal tract[M]. In: Johnson L, editor. Gastrointestinal afferent fibers and sensation. New York: Raven Press, 1994: 484–519. [38] Nicola Villanova, Fernando Azpiroz, Juan-R Malagelada. Perception and gut reflexes induced by stimulation of gastrointestinal thermoreceptors in humans[J]. J Physiol, 1997, 502(Pt 1):215–222. [39] Drewes AM, Schipper KP, Dimcevski G, et al. Multimodal assessment of pain in the esophagus: A new experimental model[J]. Am J Physiol Gastrointest Liver Physiol, 2002, 283(1):G95–103. [40] Graven-Nielsen T, Segerdahl M, Svensson P, et al. Methods for induction and assessment of pain in humans with clinical and pharmacological examples[J]. In: Kruger L, editor. Methods in pain research. Boca Raton FL: CRC Press, 2001:264–304. [41] Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness.Treatment strategies and performance factors[J]. Sports Med, 2003, 33(2):145–164. [42] Siegfried Mense. The pathogenesis of muscle pain[J]. Curr Pain Headache Rep, 2003, 7(6):419–425. [43] Weerakkody N S, Percival P, Hickey M W, et al. Effects of local pressure and vibration on muscle pain from eccentric exercise and hypertonic saline[J]. Pain, 2003, 105(3):425–435. [44] Toru Taguchi, Teru Matsuda, Ryoko Tamura, et al. Muscular mechanical hyperalgesia revealed by behavioural pain test and c-Fos expression in the spinal dorsal horn after eccentric contraction in rats[J]. J Physiol, 2005, 564(Pt 1):259–268. [45] Elie Dolgin. Animalgesic effects[J]. Nat Med, 2010, 16(11):1237–1240. [46] Lars Arendt-Nielsen, Anne E Olesen, Camilla Staahl, et al. Analgesic efficacy of peripheral kappa opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain[J]. Anesthesiology, 2009, 111(3):616–624. [47] Boris A Chizh, Tony Priestley, Michael Rowbotham, et al. Predicting therapeutic efficacy-experimental pain in human subjects[J]. Brain Res Rev, 2009, 60(1):243–254. [48] Lowe P J, Hijazi Y, Luttringer O, et al. On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development[J]. Xenobiotica,2007, 37(10-11):1331–1354. [49] Jiunn H Lin, Masayo Yamazaki. Role of P-glycoprotein in pharmacokinetics: clinical implications[J]. Clin Pharmacokinet, 2003, 42(1):59–98. [50] Wesley E Shankland. Factors that affect pain behavior[J]. Cranio, 2011, 29(2):144–154. [51] Negus S S, Vanderah T W, Brandt M R, et al. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges[J]. J Pharmacol Exp Ther, 2006, 319(2):507–514. [52] Mao Jian-ren. Translational pain research: achievements and challenges[J]. J Pain, 2009, 10(10):1001–1011. [53] Joel D Greenspan, Rebecca M Craft, Linda LeResche, et al. Studying sex and gender differences in pain and analgesia: a consensus report[J]. Pain, 2007, 132 (Suppl 1):S26–S45. [54] Arendt-Nielsen L, Curatolo M, Drewes A. Human experimental pain models in drug development: translational pain research[J]. Curr Opin Investig Drugs, 2007, 8(1):41–53. [55] Camilla Staahl, Anne Estrup Olesen, Trine Andresen, et al. Assessing analgesic actions of opioids by experimental pain models in healthy volunteers-an updated review[J]. Br J Clin Pharmacol, 2009, 68(2):149–168. [56] Anne Estrup Olesen, Camilla Staahl, Christina Brock, et al. Evoked human oesophageal hyperalgesia: a potential tool for analgesic evaluation? [J]. Basic Clin Pharmacol Toxicol, 2009, 105(2):126–136. [57] Anne Estrup Olesen, Camilla Staahl, Lars Arendt-Nielsen, et al. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study[J]. BR J Clin Pharmacol, 2010, 70(2):189–200. [58] Auqusto Caraceni, Nathan Cherny, Robin Fainsinger, et al. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care[J]. J Pain Symptom Manage, 2002, 23(3):239–255. [59] James Giordano, Kim Abramson, Mark V Boswell. Pain assessment: subjectivity, objectivity, and the use of neurotechnology[J]. Pain Physician, 2010, 13(4):305–315. [60] Frampton C L, Hughes-Webb P. The measurement of pain[J]. Clin Oncol (R Coll Radiol), 2011, 23(6):381–386. [61] Joel Katz, Ronald Melzack. Measurement of pain[J]. Surg Clin North Am, 1999, 79(2):231–252. [62] Chen Yu-fen, Danny J J Wang, John A Detre. Test-retest reliability of arterial spin labeling with common labeling strategies[J]. J Magn Reson Imaging, 2011, 33(4):940–949. [63] Jens Brondum Frøkjaer, Soren Schou Olesen, Carina Graversen, et al. Neuroimaging of the human visceral pain system—a methodological review[J]. Scand J Pain, 2011, 2(3):95–104. [64] David Borsook, Lino Becerra, Richard Hargreaves. Biomarkers for chronic pain and analgesia. Part 2: how, where, and what to look for using functional imaging[J]. Discov Med, 2011, 11(58):209–219. [65] Gjermund Henriksen, Frode Willoch. Imaging of opioid receptors in the central nervous system[J]. Brain, 2008, 131:1171–1196. [66] John R Lever. PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development[J]. Curr Pharm Des, 2007, 13(1):33–49. [67] Camilla Staahl, Anne L Krarup, Anne E Olesen, et al. Is electrical brain activity a reliable biomarker for opioid analgesia in the gut? [J]. Basic Clin Pharmacol Toxicol, 2011, 109(5):321–327. [68] Dina Lelic, Maciej Gratkowski, Kristian Hennings, et al. Multichannel matchingpursuit validation and clustering–a simulation and empirical study[J]. J Neurosci Methods, 2011 196(1):190–200. [69] Smith J K, Humes D J, Head K E, et al. fMRI and MEG analysis of visceral pain in healthy volunteers[J]. Neurogastroenterol Motil, 2011, 23(7):648-e260. [70] Abhishek Sharma, Dina Lelic, Christina Brock, et al. New technologies to investigate the brain-gut axis[J]. World J Gastroenterol, 2009, 15(2):182–191. [71] Carsten Dahl Mørch, Ole Kaseler Andersen, Thomas Graven-Nielsen, et al. Nociceptive withdrawal reflexes evoked by uniform-temperature laser heat stimulation of large skin areas in humans[J]. J Neurosci Methods, 2007, 160(1):85–92. [72] Christoph Peterbauer, Paula M Larenza, Monika Knobloch, et al. Effects of a low dose infusion of racemic and Sketamine on the nociceptive withdrawal reflex in standing ponies[J]. Vet Anaesth Analg, 2008, 35(5):414–423. [73] Giorgio Sandrini, Mariano Serrao, Paolo Rossi, et al. The lower limb flexion reflex in humans[J]. Prog Neurobiol, 2005, 77(6):353–395. [74] Alban Y Neziri, Michele Curatolo, Eveline Nuesch, et al. Factor analysis of responses to thermal, electrical, and mechanical painful stimuli supports the importance of multi-modal pain assessment[J]. Pain, 2011, 152(5):1146–1155. [75] Alban Y Neziri, Ole K Andersen, Steen Petersen-Felix, et al. The nociceptive withdrawal reflex: normative values of thresholds and reflex receptive fields[J]. Eur J Pain, 2010, 14(2):134–141. [76] Camilla Staahl, Hariprasad Reddy, Soren Due Andersen, et al. Multimodal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics[J]. Basic Clin Pharmacol Toxicol, 2006, 98(2):201–211. [77] Robert R Edwards, Eleni Sarlani, Ursula Wesselmann, et al. Quantitative assessment of experimental pain perception: multiple domains of clinical relevance[J]. Pain, 2005, 114(3):315–319. [78] Camilla Staahl, Georg Dimcevski, Soren Due Andersen, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study[J]. Scand J Gastroenterol, 2007, 42(3):383–390. [79] Camilla Staahl, Lona Louring Christrup, Soren Due Andersen, et al. A comparative study of oxycodone and morphine in a multi-modal, tissue differentiated experimental pain model[J]. Pain, 2006, 123(1-2):28–36. [80] Jan Sorensen, Ann Bengtsson, Johan Ahlner, et al. Fibromyalgia–are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs[J]. J Rheumatol, 1997, 24(8):1615–1621. [81] Per Kristian Eide, Audun Stubhaug, Ivar Oye, et al. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia[J]. Pain, 1995, 61(2):221–228. [82] Sebastian Straube, Sheena Derry, Henry J McQuay, et al. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review[J]. Br J Clin Pharmacol, 2008, 66(2):266–275. [83] Krarup A L, Ny L, Astrand M, et al. Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophagealpain[J]. Aliment Pharmacol Ther, 2011, 33(10):1113–1122. [84] Pierre Poitras, Monique Riberdy Poitras, Victor Plourde, et al. Evolution of visceral sensitivity in patients with irritable bowel syndrome[J]. Dig Dis Sci, 2002, 47(4):914–920. [85] Hanne Gottrup, Flemming W Bach, Gitte Juhl, et al. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain[J]. Anesthesiology, 2006, 104(3):527–536. [86] Anne Estrup Olesen, Trine Andresen, Camilla Staahl, et al. Human Experimental Pain Models for Assessing the Therapeutic Efficacy of Analgesic Drugs[J]. Pharmacol Rev, 2012, 64(3):722–779. [87] Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values[J]. Pain, 2006, 123(3):231–243. |
| [1] | LIU Xuan, TENG Jin-liang.Effect of Dexmedetomidine on Perioperative Analgesia[J]. Acta Neuropharmacologica, 2019, 9(6): 41-46. |
| [2] | SUN Yi，TAN Bo，SU Rui-bin.Biased Ligand——Novel Paradigm for Opioid Analgesics[J]. Acta Neuropharmacologica, 2018, 8(2): 1-7. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
